CDKN2A and glioblastoma: Although our approach focused primarily on p16Ink4a Hi senescent cells in a mouse MES-GBM model, our findings show that the senescence signature we established in this study, is applicable to GBMs regardless of p16Ink4a status (Fig. 7e).